This pictorial essay briefly discusses methods for optimizing bowel imaging with magnetic resonance imaging (MRI) and illustrates the MRI appearance of a variety of unusual lesions involving or related specifically to the large bowel.
INTRODUCTION
Imaging of the large bowel has traditionally relied on fluoroscopic techniques; however, cross-sectional modalities including computed tomography (CT ), magnetic resonance imaging (MRI), ultrasonography, and positron emission tomography-CT (PET-CT) have become commonplace since the mid 1990s. Depending on the indication and area of interest, advantages of each of these modalities vary. MRI, for example, has found clinical utility in staging of rectal carcinoma, [1, 2] with clear advantages over endoscopic, sonographic, or clinical staging. Increasing use of MR enterography (MRE) for evaluating infl ammatory bowel disease, while primarily being performed for detection and characterization of small bowel disease, also allows assessment of the colon. Dedicated MR colonography remains a rare application, most often performed in research settings as an alternative to screening CT colonography. MRI allows superior soft tissue characterization in comparison to CT and ultrasonography, and does not require ionizing radiation.
MRI for inflammatory bowel disease and rectal cancer staging represents some of the most rapidly growing segments of our body MRI practice, and the increasing volumes (and increasing scrutiny of bowel) have led to the detection of several unusual lesions involving the lower gastrointestinal (GI) tract. This pictorial essay briefl y discusses methods for optimizing bowel imaging with MRI and illustrates the MRI appearance of a variety of unusual lesions involving or related specifi cally to the large bowel.
TECHNICAL CONSIDERATIONS
MRE protocols are primarily designed to optimize assessment of small bowel in the setting of infl ammatory bowel disease; fortunately, these protocols frequently improve visualization of the large bowel as well. Eff ective MRE examinations require adequate distention of bowel, achieved by ingestion of an oral contrast agent (VoLumen ® ), reduction of peristalsis via intravenous and/or subcutaneous injection of an antiperistaltic agent (glucagon), and time-efficient protocols, typically incorporating fast T2-weighted sequences such as balanced steady-state free precession (b-SSFP) and single-shot fast spin echo (SSFSE), and dynamic gadolinium-enhanced 3D spoiled gradient recalled (SPGR) acquisitions in coronal and axial planes.
Rectal cancer staging generally requires high spatial resolution 2D fast spin echo (FSE) images [2] in three planes for adequate tumor delineation and staging. Distention of the rectum with ultrasound gel aids in visualization of the primary tumor, and is generally less useful in staging extramural tumor extension. Three small fi eld of view (FOV), high spatial resolution FSE acquisitions can be fairly time consuming, and are not infrequently degraded by artifact; these artifacts are usually related to motion from peristalsis or patient movement. We find that addition of shorter acquisitions (such as post-gadolinium 3D SPGR images and 2D SSFSE and/or b-SSFP images) can be very helpful in cases where the FSE images are signifi cantly degraded by artifact.
Lesions involving bowel may occasionally be serendipitously detected on MRI not dedicated to bowel imaging. In these cases, additional SSFSE and/or b-SSFP acquisitions in planes oriented parallel and perpendicular to the mass or to the associated bowel loop may be helpful in providing motion-free images of the lesion. Diff usion-weighted images may also be useful -these should generally be obtained with a relatively high b-value (>800 s/mm 2 ), so the T2 shine-through eff ects from fl uid within the bowel lumen are reduced.
CASES

Cecum/appendix
Primary appendiceal adenocarcinoma [ Figure 1 ] is rare in comparison to colorectal adenocarcinoma, and constitutes less than 0.5% of all neoplasms of the GI tract. It is, however, the most common appendiceal cancer. Primary appendiceal tumors are rarely diagnosed preoperatively and are found in < 2% of appendectomy specimens. [3] Primary appendiceal adenocarcinomas usually arise in pre-existing adenomas and exhibit either a cystic or colonic growth pattern. The cystic type is a mucin-producing tumor. These tumors have a tendency to rupture and spread throughout the peritoneal cavity, resulting in pseudomyxoma peritonei. Colonic type lesions (the diagnosis in this case) develop from a tubular or tubulovillous adenoma, and are comparable to colonic adenocarcinomas. [3] Appendiceal adenocarcinoma appears as an appendiceal mass on MRI, and in this case is accompanied by extensive central necrosis and local invasion of the psoas muscle. Carcinoid tumors comprise 2% of all gastrointestinal (GI) tumors and are characterized by their slow growth, neuroendocrine origin, and association with carcinoid syndrome. Most carcinoid tumors arise in the distal ileum within 2 feet of the ileocecal valve (a proclivity shared with Meckel's diverticulum) and some authors have found the appendix to be a relatively common site of origin. [4, 5] Most appendiceal carcinoids are serotonin-producing enterochromaffi n cell tumors, making them more similar to jejunal and ileal carcinoids than to colonic carcinoids. MRI features of carcinoid tumors of the GI tract are nonspecifi c and can include heterogeneous, predominantly hypointense T1 signal, hyperintense T2 signal, and a heterogeneously enhancing, well-defi ned nodular mass or regional, relatively uniform segmental mural thickening of the bowel. Early imaging features of appendiceal carcinoid can mimic infl ammatory disease. Clinical history including cutaneous fl ushing, diarrhea, vague intermittent abdominal pain, and elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) and serum chromogranin A levels may help in distinguishing carcinoid from other neoplastic and infl ammatory diseases, and the diagnosis and extent can be confi rmed with Indium ( 111 In)-octreotide scintigraphy and more recently with 11C-5-hydroxytryptophan (11C-5-HTP) PET. [6] Figure 2 shows an appendiceal carcinoid tumor with a well-defi ned nodular hyperenhancing mass on MRI.
Cecal carcinoma can have a variety of presentations, and not infrequently, as in this case, may be entirely asymptomatic and detected incidentally [ Figure 3 ]. The survival rate of cecal carcinoma compared to other colon cancers has been deliberated for decades [7] with earlier reports describing a poorer prognosis that was thought to result from its tendency to present with vague, chronic symptoms, including pain, weight loss, and anemia, as well as its anatomy and physiology. However, subsequent investigations could not substantiate this and either found similar or higher [8] survival rates for cecal carcinoma, suggesting that prognosis is best predicted by clinicopathologic staging. [7] The heterogeneously hypoenhancing mural mass shown in Figure 3 is a fairly typical appearance, and the high signal intensity seen on the SSFSE image likely refl ects the substantial mucinous componentof the tumor.
Ascending colon
Angiodysplasias of the GI tract [ Figure 4 ] are characterized by vascular abnormalities of the submucosal and mucosal layers and include hemangiomas, arteriovenous malformations, and angiosarcomas. Most lesions are found in the cecum and ascending colon of patients older than 60 years of age. The most common signs and symptoms when present are associated with GI bleeding, which can be recurrent or chronic.
Endoscopic imaging is currently the main tool for diagnosis in the upper and lower GI tract, while capsule endoscopy is often used for the small bowel. [9, 10] MR or CT angiography, or catheter-based angiography is often used to confirm the location of suspected bleeding or to further evaluate for a primary diagnosis. While arterial phase images from a standard dynamic contrast-enhanced 3D SPGR acquisition [as shown in Figure 4 ] are usually sufficient to make the diagnosis, if a vascular lesion is suspected, MR angiographic acquisitions using an intravascular gadolinium contrast agent might improve the sensitivity for detection of subtle lesions.
Transverse colon
Hepatic flexure adenocarcinoma [ Figure 5 ] is considered a cancer of the right-sided colon, which anatomically includes the cecum, ascending colon, hepatic flexure, and transverse colon. Some studies have investigated the histopathologic expression of colorectal cancer depending on tumor location and observed that right-sided colon cancers tended to be bulky, polypoid, and exophytic while left-sided cancers tended to be infi ltrative, circumferential, and associated with luminal narrowing. [11] [12] [13] Colon cancers located in the hepatic fl exure, splenic fl exure, or transverse colon can often be included in the FOV of standard abdominal examinations performed to screen for hepatic metastases, and small modifi cations of standard protocols may provide additional information regarding nodal or peritoneal disease, vascular invasion, and local tumor extension.
Descending colon
Lipomas [ Figure 6 ] are the most common benign mesenchymal tumor of the colon with a frequency as high as 6% in clinical and autopsy series. [14, 15] These tumors comprise well-differentiated fatty tissue surrounded by a thin fibrous capsule which lends itself to a sharply circumscribed morphology on cross-sectional imaging. Lipomas occur more frequently in the right colon and are most common near the ileocecal valve, and this case is presented in this section due to its uncommon location. Patients are generally asymptomatic, particularly when the tumors are relatively small, but lesions larger than 3-4 cm in diameter may cause intussusception or obstruction and patients can present with abdominal pain or discomfort, bleeding per rectum, or a change in bowel habits.
The diagnosis of lipoma is made by demonstrating that the lesion follows the signal intensity of mesenteric or subcutaneous fat on acquisitions performed without and with fat suppression -typically SSFSE and/or b-SSFP images in an MRE examination, or alternatively by examination of fat and water images from a Dixon 3D SPGR acquisition.
Sigmoid colon
Mesenchymal lesions of the GI tract include gastrointestinal stromal tumors (GISTs), lipomas, desmoid tumors, schwannomas, and true smooth muscle neoplasms. True smooth muscle neoplasms of the GI tract, such as leiomyomas [ Figure 7 ] and leiomyosarcomas, show smooth muscle differentiation by light microscopy and lack CD117 (KIT mutations), in contrast to GISTs.
In the GI tract, polypoid leiomyomas are more common than intramural leiomyomas and in one review of 85 cases, [16] the polypoid form involved largely the colorectum (with the sigmoid colon and rectum being more frequent) and the intramural form involved the esophagus, stomach, and ileum. Polypoid leiomyomas manifest as small sessile polyps, while intramural leiomyomas form well-circumscribed lobulated masses arising from the muscularis propria and bulging into the mucosa or serosa. MRI features [ Figure 7 ] include a mildly heterogeneous appearance, frequently with low signal intensity on T2-weighted images, and significant enhancement following gadolinium administration.
Diverticulitis can be diagnostically challenging both clinically where gynecologic abnormalities can be confounding and radiologically [ Figure 8 ] where imaging differential diagnoses include colon cancer and ischemia. [17] CT is the imaging modality of choice for evaluation of suspected diverticulitis. CT and MRI features that are associated with, but not exclusive to diverticulitis include soft tissue stranding suggesting infl ammation, bowel wall thickening, mural enhancement, abscess formation, and localized or diff use pneumoperitoneum. The high sensitivity of CT (and likely MRI) for detection of diverticulitis is not matched by a corresponding high specifi city, as emphasized in Figure 8 , which was interpreted as suspicious for carcinoma; therefore, it is important to document resolution of disease and exclude an underlying malignancy.
The rectosigmoid colon is the most common site of bowel involvement by metastatic or recurrent ovarian carcinoma [ Figure 9 ], and can occur from direct extension or peritoneal seeding. Metastases from ovarian cancer usually invade the bowel serosa, resulting in characteristic tethering and kinking, and may ultimately cause obstruction. MRI can often demonstrate an eccentric mass, and the diagnosis is usually straightforward in a patient with a history of ovarian carcinoma.
Rectum
Plexiform neurofi bromas are benign peripheral nerve sheath tumors that comprise a complex network (plexiform) of peripheral nerves arranged in a tortuous confi guration. of the sigmoid colon with diffuse restricted diffusion and mild mural enhancement (arrow). There is associated obstruction with dilation of the sigmoid colon proximal to the lesion. This was described as highly suspicious for malignancy. Endoscopic biopsy was negative for malignancy; however, conservative clinical management was unsuccessful and surgery was recommended given his persistent symptoms and obstruction. These tumors are pathognomonic of neurofi bromatosis I (NF1) and are found in about 30% of NF1 cases. Plexiform neurofibromas are usually congenital or appear in childhood, and often have rapid enlargement during adolescence. They may persist for years without causing significant symptoms; however, when they do cause neurologic deficits, medical or surgical treatment is diffi cult.
While neurofi bromas classically exhibit high signal intensity on T2-weighted images and moderate enhancement following gadolinium administration, plexiform lesions, particularly those involving very small nerves, may show only mild increased T2 signal intensity and enhancement, and often, as in this case, the most striking appearance is seen on T1-weighted images [ Figure 10 ]. Diagnosis is often aided by identification of multiple subcutaneous neurofi bromas (if the history of NF1 is not known or has not been provided).
Mesenchymal tumors of the GI tract were generally classified as leiomyomas or leiomyosarcomas until the 1980s when it was discovered that a number of these lesions lacked features of smooth muscle and expressed antigens related to neural crest cells. More specifically, GISTs [ Figure 11 ] are defi ned as spindle cell, epithelioid, pleomorphic mesenchymal tumors that express the Kit protein (this is a stem cell factor receptor protein), and activation of the receptor leads to unchecked cell growth and resistance to apoptosis.
GISTs are relatively rare tumors, accounting for 1-3% of all GI neoplasms, with approximately 2000 new cases diagnosed annually in the United States. The peak age of incidence is 50-60 years, with a slight male predominance. Most tumors arise in the stomach (60-70%) or small intestine (20-30%), with the lesions found less frequently in the esophagus, mesentery, colon, or rectum. Approximately 20-30% of the lesions are malignant, with the liver and peritoneal cavity being the most common sites of metastases.
The appearance on MRI has not been well documented in the literature. In general, larger lesions tend to exhibit heterogeneous enhancement which persists on venous and equilibrium phase images and multiple regions of cystic degeneration or necrosis with high T2 signal intensity, while smaller lesions may have a more uniform appearance. Lesion growth can be exophytic or intraluminal, and exophytic lesions are often quite large by the time they become symptomatic.
Rectal varices [ Figure 12 ] represent a portal-systemic collateral pathway that usually develops in the setting of portal hypertension or obstructed portal venous fl ow. The rectum is a site of overlapping portal and systemic venous drainage: Superior hemorrhoidal veins of the inferior mesenteric system and the middle and inferior hemorrhoidal veins of the iliac system.
Rectal varices consist of small venous collateral vessels within the rectal wall and in the perirectal region. The appearance can become somewhat mass-like, as seen in Figure 12 , and a circumferential rectal hemangioma can have a very similar appearance. The highly vascular nature of the lesion is generally apparent, however, and should not be mistaken for a rectal carcinoma.
Small cell carcinoma (SCC) aff ecting the colon and rectum [ Figure 13 ] is rare, accounting for approximately 0.2% of all colorectal cancers. Three subtypes have been described: Undifferentiated SCC, neuroendocrine carcinoma, and stem cell carcinoma. Histologic diagnosis is confirmed by documenting the presence of at least two of three immunohistochemical markers, the most common of which is synaptophysin.
The rectum is the most common location for SCC, followed by the cecum and sigmoid. As is true of SCC in other locations, rectal lesions tend to show aggressive behavior. Most patients (70-80%) have liver or nodal metastases at diagnosis, and the prognosis is generally poor, with 6-month survival of 58% and 5-year survival of approximately 6%.
The appearance of rectal SCC has not been well described in the MR literature; however, the large, diff usely infi ltrative lesion illustrated in this case is likely a fairly typical example. While it is probably unrealistic to arrive at a specific diagnosis, the appearance might suggest a differential diagnosis including an unusually aggressive rectal carcinoma as well as lymphoma and metastasis.
Primary rectal lymphoma [ Figure 14 ] is rare, representing 0.1-0.4% of primary rectal tumors. [18] [19] [20] Although the GI tract is a common site of extranodal lymphoma, colorectal involvement is relatively infrequent (6-20% of GI lymphomas) and is associated with a worse prognosis. [21, 22] B-cell and mucosa-associated lymphoid tissue (MALT) lymphomas are the most common colorectal lymphomas.
Imaging findings are nonspecific and can overlap with rectal adenocarcinomas. One feature that may help to distinguish lymphoma from adenocarcinoma is the absence of proximal bowel obstruction that is often associated with adenocarcinomas of similar size. Extensive regional lymphadenopathy is often seen with secondary rectal lymphoma. MRI demonstrates a mural or, less frequently, a polypoid mass which typically has a mildly heterogeneous appearance and intermediate signal intensity on T2-weighted images, high signal intensity on diffusion-weighted images, and mild enhancement following gadolinium administration. Figure 15 shows an unusual presentation of metastatic disease involving the rectum. Metastases to the intestine are relatively uncommon, more frequently involve small bowel, and generally present as focal submucosal masses. Rectal metastases have been reported from primary tumors including prostate, bladder, breast, ovarian, lung, and gastric cancer, as well as melanoma and malignant fi brous histiocytoma.
Diff use annular involvement of the rectum is an unusual presentation for metastatic disease, but has been described in patients with primary bladder urothelial cell carcinoma. The absence of the bladder and prostate (with susceptibility artifact from surgical clips visible on the post-gadolinium images) is also a clue to the diagnosis. The differential diagnosis includes primary rectal adenocarcinoma, and the long annular lesion could also be seen with lymphoma.
Anus
Anal mucinous adenocarcinoma [ Figure 16 ] is a rare malignancy accounting for about 3% of anal cancers. [23, 24] Squamous cell carcinoma is similarly rare, but is strongly associated with the human papillomavirus. Presentation of anal cancer is variable, but generally includes anal pain, bleeding, or itching. Cross-sectional imaging is usually performed for evaluating for regional extent of the disease.
CONCLUSIONS
This pictorial essay illustrates the appearance of a variety of unusual large bowel pathologies on MRI. While several of the above cases were imaged using dedicated enterography or rectal protocols, many others were discovered serendipitously during abdominal or pelvic examinations performed for diff erent indications. Optimal MRI of large bowel lesions includes luminal distention, administration of antiperistaltic agents, and the use of rapid imaging techniques including SSFSE and b-SSFP acquisitions. Even when dedicated protocols are not performed, however, adequate characterization of incidental large bowel lesions is often possible, particularly if additional sequences can be performed before the patient is dismissed. 
